Trial intelligence / Profile preview

Safety and Efficacy of Maturameha Extract as Add-On Medication in Type 2 Diabetic Patients

TCTR20240622003Phase 2Completed

Sponsor
Medicinal Innovation Center
Start
Jan 2022
Countries
1
01

Overview

Phase 2 trial in type 2 diabetes mellitus (T2DM), sponsored by Medicinal Innovation Center. Started Jan 2022; status: completed.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on TCTR20240622003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240622003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call